Vojo P. Deretic
17Patents
3h-index
11Co-inventors
57Inventor score
Filing activity: Feb 12, 1993 → Dec 29, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7897400B2 | Non-invasive rapid diagnostic test for M. tuberculosis infection | Physics | 14 | Active |
| US5573910A | Detection of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients involving the algu gene | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6083691A | Detection of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients | Chemistry; Metallurgy | 4 | Expired |
| US7717857B2 | Diagnosis of P. aeruginosa infection in the lungs of patients | Physics | 3 | Active |
| US5591838A | Detection of conversion to mucoidy in pseudomonas aeruginosa infecting cystic fibrosis patients | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6426187B1 | Detection of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients | Chemistry; Metallurgy | 3 | Expired |
| US9572820B2 | Methods of treating autophagy-associated disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits | Physics | 2 | Active |
| US12285470B2 | Trim proteins and galectins cooperate and codirect autophagy and are useful in the treatment of autophagy related diseases | Human Necessities | 0 | Active |
| US11331284B2 | Isotope enhanced ambroxol for long lasting autophagy induction | Human Necessities | 0 | Active |
| US10583099B2 | Isotope enhanced ambroxol for long lasting autophagy induction | Human Necessities | 0 | Active |
| US11819498B2 | Methods and compositions for treating autophagy related disease states and conditions utilizing AMPK activation | Human Necessities | 0 | Active |
| US8921569B2 | Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution | Chemistry; Metallurgy | 0 | Active |
| US10736910B2 | Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits | Physics | 0 | Active |
| US10610564B2 | IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy | Human Necessities | 0 | Active |
| USRE44533E1 | Diagnosis of infection in the lungs of patients | General | 0 | Active |
| US8394839B2 | Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution | Chemistry; Metallurgy | 0 | Active |
| US11878018B1 | Phosphorylation of Syntaxin 17 by TBK1 controls autophagy initiation | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.